Showing results (171-180 of 192) with videos related to
Sort By:
Pageof 20
International Journal of Biological Sciences|June 16, 2023
Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting ProdrugJen-Chih Tseng, Jing-Xing Yang, Chia-Yin Lee, et al.Liver Cancer|May 14, 2020
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTai-Chung Tseng, Cheng-Yuan Peng, Yao-Chun Hsu, et al.JHEP Reports : Innovation in Hepatology|April 19, 2021
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconvertersSu-Ru Lin, Ta-Yu Yang, Cheng-Yuan Peng, et al.Journal of Medical Virology|May 15, 2024
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antiviralsChen-Hua Liu, Yu-Ping Chang, Ji-Yuh Lee, et al.Alimentary Pharmacology & Therapeutics|February 21, 2025
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus InfectionYu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, et al.Journal of Gastroenterology|April 13, 2024
Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antiviralsChen-Hua Liu, Yu-Ping Chang, Yu-Jen Fang, et al.Nature Immunology|April 16, 2013
Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infectionLi-Rung Huang, Dirk Wohlleber, Florian Reisinger, et al.Scientific Reports|May 13, 2017
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosisTung-Hung Su, Chung-Wai Shiau, Ping Jao, et al.Open Forum Infectious Diseases|August 5, 2022
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR StudyChen-Hua Liu, Hsin-Yun Sun, Cheng-Yuan Peng, et al.Journal of Gastroenterology and Hepatology|November 14, 2025
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseYun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee, et al.Pageof 20